Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poon

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
British Journal of Pharmacology|December 24, 2016
Anti-CD22 and anti-CD79b antibody-drug conjugates preferentially target proliferating B cellsFranklin K Fuh, Caroline Looney, Dongwei Li, et al.
Transcription|July 10, 2012
The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymesYi Qing He, Elissa L Sutcliffe, Karen L Bunting, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 22, 2012
Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donorsK K Khush, L Pawlikowska, R L Menza, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilizationA Sapru, J G Zaroff, L Pawlikowska, et al.
Human Mutation|February 22, 2002
Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese populationUi-Soon Khoo, Kelvin Y K Chan, Annie N Y Cheung, et al.
British Journal of Cancer|September 6, 2006
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotideJ Cebon, M Findlay, C Hargreaves, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|July 6, 2010
Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong KongE P Hui, L K S Leung, F Mo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancerJ F Liu, K N Moore, M J Birrer, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Molecular Cancer Therapeutics|November 3, 2019
Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
British Journal of Pharmacology|December 24, 2016
Anti-CD22 and anti-CD79b antibody-drug conjugates preferentially target proliferating B cellsFranklin K Fuh, Caroline Looney, Dongwei Li, et al.
Transcription|July 10, 2012
The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymesYi Qing He, Elissa L Sutcliffe, Karen L Bunting, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 22, 2012
Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donorsK K Khush, L Pawlikowska, R L Menza, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilizationA Sapru, J G Zaroff, L Pawlikowska, et al.
Human Mutation|February 22, 2002
Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese populationUi-Soon Khoo, Kelvin Y K Chan, Annie N Y Cheung, et al.
British Journal of Cancer|September 6, 2006
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotideJ Cebon, M Findlay, C Hargreaves, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|July 6, 2010
Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong KongE P Hui, L K S Leung, F Mo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancerJ F Liu, K N Moore, M J Birrer, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Molecular Cancer Therapeutics|November 3, 2019
Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Pageof 12